Moorthy S. S. Palanki

1.1k citations

28 papers · 818 indexed · h-index 18

Co-authors: Lynn J. Ransone Anthony M. Manning Mark J. Suto Paul Erdman Dale L. Boger Mark E. Goldman Robert W. Sullivan Paul P. Tak
Topics: NF-κB Signaling Pathways (8 papers)Cytokine Signaling Pathways and Interactions (8 papers)Chemical Synthesis and Analysis (5 papers)
Cited by: Organic Chemistry Cancer Research Toxicology
Journals: Journal of the American Chemical Society Blood The Journal of Immunology
Partner nations: United States Switzerland Japan

In The Last Decade

Moorthy S. S. Palanki

28 papers receiving 759 citations

Peers

Countries citing papers authored by Moorthy S. S. Palanki

Since Specialization

Citations

This map shows the geographic impact of Moorthy S. S. Palanki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moorthy S. S. Palanki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moorthy S. S. Palanki more than expected).

Fields of papers citing papers by Moorthy S. S. Palanki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moorthy S. S. Palanki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moorthy S. S. Palanki. The network helps show where Moorthy S. S. Palanki may publish in the future.

Co-authorship network of co-authors of Moorthy S. S. Palanki

This figure shows the co-authorship network connecting the top 25 collaborators of Moorthy S. S. Palanki. A scholar is included among the top collaborators of Moorthy S. S. Palanki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moorthy S. S. Palanki. Moorthy S. S. Palanki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Jie Huang,Tetsuya Ishino,Gang Chen,(unknown),(unknown),Kelsey N. Retting,Lingna Li,Ping Jin,(unknown),Bernard Huyghe,Saswata Talukdar,Curt W. Bradshaw,Moorthy S. S. Palanki,Bernard N. Violand,Gary Woodnutt,Rodney W. Lappe,Kathleen M. Ogilvie,Nathan W. Levin	102
2	Development of a long acting human growth hormone analog suitable for once a week dosing 2012 ·Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki,Abhijit Bhat,Ben Bolaños,Florence M. Brunel,(unknown),(unknown),(unknown),Rodney W. Lappe,(unknown),Annette Sievers,(unknown),(unknown),Gang Chen	15
3	Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma. 2009 ·PubMed ·Rodrigo Moore‐Carrasco,Sı́lvia Busquets,Maite Figueras,Moorthy S. S. Palanki,Francisco J. López‐Soriano,Josep M. Argilés	10
4	Inhibitors of ABL and the ABL-T315I Mutation 2008 ·Current Topics in Medicinal Chemistry ·Glenn Noronha,Jianguo Cao,(unknown),Elena Dneprovskaia,Richard Fine,John Hood,Xinshan Kang,Boris Klebansky,(unknown),C. H. Mak,A. McPherson,Moorthy S. S. Palanki,Ved P. Pathak,(unknown),Richard Söll,(unknown)	34
5	Development of novel benzotriazines for drug discovery 2008 ·Expert Opinion on Drug Discovery ·Moorthy S. S. Palanki,Jianguo Cao,(unknown),Elena Dneprovskaia,Chi Ching Mak,A. McPherson,Ved P. Pathak,(unknown),Richard Söll,(unknown),Glenn Noronha	11
6	Inhibition of Nuclear Factor-κB in T Cells Suppresses Lung Fibrosis 2007 ·American Journal of Respiratory and Critical Care Medicine ·Hajime Fujimoto,Corina N. D’Alessandro‐Gabazza,Moorthy S. S. Palanki,Paul Erdman,Takehiro Takagi,Esteban C. Gabazza,Nelson E. Bruno,Yutaka Yano,Tatsuya Hayashi,Shigenori Tamaki,Yasuhiro Sumida,Yukihiko Adachi,Koji Suzuki,Osamu Taguchi	21
7	The design and preliminary structure–activity relationship studies of benzotriazines as potent inhibitors of Abl and Abl-T315I enzymes 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jianguo Cao,Richard Fine,(unknown),John Hood,Xinshan Kang,Boris Klebansky,(unknown),Chi Ching Mak,A. McPherson,Glenn Noronha,Moorthy S. S. Palanki,Ved P. Pathak,(unknown),Richard Söll,(unknown),Hong Zhu	21
8	Discovery of 3,3‘-(2,4-Diaminopteridine-6,7-diyl)diphenol as an Isozyme-Selective Inhibitor of PI3K for the Treatment of Ischemia Reperfusion Injury Associated with Myocardial Infarction 2007 ·Journal of Medicinal Chemistry ·Moorthy S. S. Palanki,Elena Dneprovskaia,John Doukas,Richard Fine,John Hood,Xinshan Kang,(unknown),Michael Martin,Glenn Noronha,Richard Söll,Wolfgang Wrasidlo,Shiyin Yee,Hong Zhu	40
9	The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of In vitro and In vivo studies 2003 ·Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki,Paul Erdman,(unknown),Mark J. Suto,Brydon L. Bennett,Anthony M. Manning,Lynn J. Ransone,(unknown),Sonal J. Desai,(unknown),(unknown),Peter Tsao,Wataru Toriumi	32
10	Inhibitors of AP-1 and NF-κB Mediated Transcriptional Activation: Therapeutic Potential in Autoimmune Diseases and Structural Diversity 2002 ·Current Medicinal Chemistry ·Moorthy S. S. Palanki	53
11	Structure–Activity Relationship Studies of Ethyl 2-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate: An Inhibitor of AP-1 and NF-κB Mediated Gene Expression 2002 ·Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki,(unknown),(unknown),Paul Erdman,(unknown),Mark E. Goldman,Lynn J. Ransone,(unknown)	36
12	The Effect of a T Cell-Specific NF-κB Inhibitor on In Vitro Cytokine Production and Collagen-Induced Arthritis 2000 ·The Journal of Immunology ·Daniëlle M. Gerlag,Lynn J. Ransone,Paul P. Tak,Zuoning Han,Moorthy S. S. Palanki,Miguel Barbosa,David Boyle,Anthony M. Manning,Gary S. Firestein	89
13	Novel inhibitors of AP-1 and NF-κB mediated gene expression: structure–activity relationship studies of ethyl 4-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)pyrimidine-5-carboxylate 2000 ·Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki,Paul Erdman,Anthony M. Manning,(unknown),Lynn J. Ransone,(unknown),Carla M. Suto,Mark J. Suto	29
14	Interleukin-2 inhibitors in autoimmune disease 1999 ·Expert Opinion on Therapeutic Patents ·Moorthy S. S. Palanki,Anthony M. Manning	7
15	ChemInform Abstract: 2‐Chloro‐4‐(trifluoromethyl)pyrimidine‐5‐N‐(3′,5′‐bis (trifluoromethyl)phenyl)carboxamide: A Potent Inhibitor of NF‐ϰB‐ and AP‐1‐Mediated Gene Expression Identified Using Solution‐Phase Combinatorial Chemistry. 1998 ·ChemInform ·Robert W. Sullivan,(unknown),Paul Erdman,Moorthy S. S. Palanki,David W. Anderson,Mark E. Goldman,Lynn J. Ransone,Mark J. Suto	2
16	Solution-phase parallel synthesis using ion-exchange resins 1998 ·Tetrahedron ·Mark J. Suto,(unknown),Moorthy S. S. Palanki,(unknown)	29
17	Immunospecific Reduction of Antioligonucleotide Antibody-Forming Cells with a Tetrakis-oligonucleotide Conjugate (LJP 394), a Therapeutic Candidate for the Treatment of Lupus Nephritis 1995 ·Journal of Medicinal Chemistry ·D. Stephen Charnock‐Jones,P A Barstad,(unknown),John Hachmann,(unknown),Kenneth W. Hill,G. Michael Iverson,(unknown),Moorthy S. S. Palanki	52
18	Evaluation of functional Analogs of CC-1065 and the Duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (C2BI) alkylation subunit 1993 ·Bioorganic & Medicinal Chemistry ·Dale L. Boger,Douglas S. Johnson,Moorthy S. S. Palanki,Paul A. Kitos,Jiyoung Chang,(unknown)	21
19	Structures of two conformationally defined phenylethanolamines: exo-1,4-epoxy-2-formamido-1,2,3,4-tetrahydro-8-trifluoromethylnaphthalene and exo-1,4-epoxy-2-formamido-1,2,3,4-tetrahydro-6-trifluoromethylnaphthalene 1991 ·Acta Crystallographica Section C Crystal Structure Communications ·Gary L. Grunewald,Moorthy S. S. Palanki,Fusao Takusagawa	2
20	ONE-STEP SYNTHESIS OF TRIFLUOROMETHYL- AND OF METHOXY-SUBSTITUTED BENZYNE PRECURSORS 1990 ·Organic Preparations and Procedures International ·Gary L. Grunewald,(unknown),Moorthy S. S. Palanki,Vidyadhar M. Paradkar,(unknown),Daniel J. Sall	3

About Moorthy S. S. Palanki

Moorthy S. S. Palanki is a scholar working on Cancer Research, Organic Chemistry and Oncology, having authored 28 papers that have together received 818 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (8 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Organic Chemistry (297 citations), Cancer Research (118 citations) and Toxicology (23 citations). Moorthy S. S. Palanki has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Lynn J. Ransone, Anthony M. Manning, Mark J. Suto, Paul Erdman, Dale L. Boger, Mark E. Goldman, Robert W. Sullivan, Paul P. Tak, Brydon L. Bennett and Daniëlle M. Gerlag. Their work appears in journals such as Journal of the American Chemical Society, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact